nodes	percent_of_prediction	percent_of_DWPC	metapath
Cetrorelix—LHCGR—Arf6 signaling events—ADRB2—chronic obstructive pulmonary disease	0.0386	0.085	CbGpPWpGaD
Cetrorelix—LHCGR—Peptide GPCRs—CXCR2—chronic obstructive pulmonary disease	0.0338	0.0745	CbGpPWpGaD
Cetrorelix—Glaucoma—Tiotropium—chronic obstructive pulmonary disease	0.0295	0.0541	CcSEcCtD
Cetrorelix—LHCGR—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	0.0277	0.0611	CbGpPWpGaD
Cetrorelix—Glaucoma—Formoterol—chronic obstructive pulmonary disease	0.0238	0.0436	CcSEcCtD
Cetrorelix—Glaucoma—Arformoterol—chronic obstructive pulmonary disease	0.0238	0.0436	CcSEcCtD
Cetrorelix—GNRHR—Peptide GPCRs—CXCR2—chronic obstructive pulmonary disease	0.0226	0.0499	CbGpPWpGaD
Cetrorelix—Contusion—Montelukast—chronic obstructive pulmonary disease	0.0202	0.0369	CcSEcCtD
Cetrorelix—GNRHR—GPCRs, Other—CXCR2—chronic obstructive pulmonary disease	0.0192	0.0423	CbGpPWpGaD
Cetrorelix—Anaphylactoid reaction—Aminophylline—chronic obstructive pulmonary disease	0.0177	0.0324	CcSEcCtD
Cetrorelix—Immune system disorder—Roflumilast—chronic obstructive pulmonary disease	0.016	0.0294	CcSEcCtD
Cetrorelix—LHCGR—G alpha (s) signalling events—ADRB2—chronic obstructive pulmonary disease	0.014	0.0309	CbGpPWpGaD
Cetrorelix—LHCGR—Arf6 signaling events—EGFR—chronic obstructive pulmonary disease	0.0136	0.03	CbGpPWpGaD
Cetrorelix—Glaucoma—Prednisolone—chronic obstructive pulmonary disease	0.0129	0.0236	CcSEcCtD
Cetrorelix—LHCGR—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.0124	0.0274	CbGpPWpGaD
Cetrorelix—GNRHR—GPCRs, Other—ADRB2—chronic obstructive pulmonary disease	0.012	0.0265	CbGpPWpGaD
Cetrorelix—LHCGR—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.0107	0.0235	CbGpPWpGaD
Cetrorelix—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.0101	0.0185	CcSEcCtD
Cetrorelix—GNRHR—GPCRs, Other—HTR2A—chronic obstructive pulmonary disease	0.0094	0.0207	CbGpPWpGaD
Cetrorelix—Glaucoma—Prednisone—chronic obstructive pulmonary disease	0.00938	0.0172	CcSEcCtD
Cetrorelix—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.0093	0.017	CcSEcCtD
Cetrorelix—Cough—Tiotropium—chronic obstructive pulmonary disease	0.00848	0.0155	CcSEcCtD
Cetrorelix—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00841	0.0154	CcSEcCtD
Cetrorelix—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00814	0.0149	CcSEcCtD
Cetrorelix—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00814	0.0149	CcSEcCtD
Cetrorelix—LHCGR—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.00812	0.0179	CbGpPWpGaD
Cetrorelix—Contusion—Prednisone—chronic obstructive pulmonary disease	0.0081	0.0148	CcSEcCtD
Cetrorelix—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00798	0.0146	CcSEcCtD
Cetrorelix—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00796	0.0146	CcSEcCtD
Cetrorelix—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00795	0.0146	CcSEcCtD
Cetrorelix—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00791	0.0145	CcSEcCtD
Cetrorelix—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00786	0.0144	CcSEcCtD
Cetrorelix—LHCGR—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.00781	0.0172	CbGpPWpGaD
Cetrorelix—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00769	0.0141	CcSEcCtD
Cetrorelix—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.0075	0.0137	CcSEcCtD
Cetrorelix—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.00729	0.0133	CcSEcCtD
Cetrorelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00714	0.0157	CbGpPWpGaD
Cetrorelix—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00685	0.0125	CcSEcCtD
Cetrorelix—Cough—Formoterol—chronic obstructive pulmonary disease	0.00685	0.0125	CcSEcCtD
Cetrorelix—Cough—Montelukast—chronic obstructive pulmonary disease	0.00671	0.0123	CcSEcCtD
Cetrorelix—LHCGR—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00669	0.0147	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00665	0.0147	CbGpPWpGaD
Cetrorelix—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00647	0.0118	CcSEcCtD
Cetrorelix—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.0064	0.0117	CcSEcCtD
Cetrorelix—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.0064	0.0117	CcSEcCtD
Cetrorelix—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00627	0.0115	CcSEcCtD
Cetrorelix—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.0062	0.0114	CcSEcCtD
Cetrorelix—LHCGR—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.0061	0.0134	CbGpPWpGaD
Cetrorelix—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00605	0.0111	CcSEcCtD
Cetrorelix—GNRHR—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.00604	0.0133	CbGpPWpGaD
Cetrorelix—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00598	0.011	CcSEcCtD
Cetrorelix—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00598	0.011	CcSEcCtD
Cetrorelix—LHCGR—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.00598	0.0132	CbGpPWpGaD
Cetrorelix—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00595	0.0109	CcSEcCtD
Cetrorelix—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00585	0.0107	CcSEcCtD
Cetrorelix—LHCGR—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.00569	0.0125	CbGpPWpGaD
Cetrorelix—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00565	0.0103	CcSEcCtD
Cetrorelix—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00561	0.0103	CcSEcCtD
Cetrorelix—GNRHR—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.00543	0.012	CbGpPWpGaD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.0054	0.0119	CbGpPWpGaD
Cetrorelix—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00531	0.00971	CcSEcCtD
Cetrorelix—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.0053	0.0097	CcSEcCtD
Cetrorelix—GNRHR—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.00528	0.0116	CbGpPWpGaD
Cetrorelix—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00527	0.00965	CcSEcCtD
Cetrorelix—LHCGR—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.00523	0.0115	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.00517	0.0114	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.00509	0.0112	CbGpPWpGaD
Cetrorelix—Rash—Tiotropium—chronic obstructive pulmonary disease	0.005	0.00916	CcSEcCtD
Cetrorelix—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.005	0.00915	CcSEcCtD
Cetrorelix—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.005	0.00915	CcSEcCtD
Cetrorelix—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00497	0.0091	CcSEcCtD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.00473	0.0104	CbGpPWpGaD
Cetrorelix—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00472	0.00864	CcSEcCtD
Cetrorelix—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00472	0.00864	CcSEcCtD
Cetrorelix—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00471	0.00863	CcSEcCtD
Cetrorelix—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00462	0.00846	CcSEcCtD
Cetrorelix—LHCGR—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.00459	0.0101	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.00455	0.01	CbGpPWpGaD
Cetrorelix—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00453	0.0083	CcSEcCtD
Cetrorelix—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00453	0.0083	CcSEcCtD
Cetrorelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00448	0.00987	CbGpPWpGaD
Cetrorelix—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00446	0.00816	CcSEcCtD
Cetrorelix—GNRHR—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00445	0.00981	CbGpPWpGaD
Cetrorelix—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00444	0.00812	CcSEcCtD
Cetrorelix—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00428	0.00783	CcSEcCtD
Cetrorelix—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00425	0.00778	CcSEcCtD
Cetrorelix—LHCGR—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.00417	0.00918	CbGpPWpGaD
Cetrorelix—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00404	0.00739	CcSEcCtD
Cetrorelix—Rash—Formoterol—chronic obstructive pulmonary disease	0.00404	0.00739	CcSEcCtD
Cetrorelix—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00403	0.00739	CcSEcCtD
Cetrorelix—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00403	0.00739	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.00403	0.00888	CbGpPWpGaD
Cetrorelix—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00401	0.00735	CcSEcCtD
Cetrorelix—Headache—Formoterol—chronic obstructive pulmonary disease	0.00401	0.00735	CcSEcCtD
Cetrorelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.004	0.00882	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.00398	0.00877	CbGpPWpGaD
Cetrorelix—Rash—Montelukast—chronic obstructive pulmonary disease	0.00396	0.00724	CcSEcCtD
Cetrorelix—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00395	0.00723	CcSEcCtD
Cetrorelix—Headache—Montelukast—chronic obstructive pulmonary disease	0.00393	0.00719	CcSEcCtD
Cetrorelix—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00381	0.00698	CcSEcCtD
Cetrorelix—GNRHR—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.00381	0.0084	CbGpPWpGaD
Cetrorelix—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00381	0.00697	CcSEcCtD
Cetrorelix—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.0038	0.00696	CcSEcCtD
Cetrorelix—Nausea—Formoterol—chronic obstructive pulmonary disease	0.0038	0.00696	CcSEcCtD
Cetrorelix—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00379	0.00694	CcSEcCtD
Cetrorelix—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00373	0.00682	CcSEcCtD
Cetrorelix—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00359	0.00658	CcSEcCtD
Cetrorelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.0035	0.00771	CbGpPWpGaD
Cetrorelix—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00347	0.00635	CcSEcCtD
Cetrorelix—GNRHR—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.00346	0.00762	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.00341	0.00751	CbGpPWpGaD
Cetrorelix—LHCGR—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.00323	0.00712	CbGpPWpGaD
Cetrorelix—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.0032	0.00587	CcSEcCtD
Cetrorelix—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00309	0.00565	CcSEcCtD
Cetrorelix—GNRHR—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.00307	0.00677	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.00305	0.00673	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.00305	0.00671	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.00288	0.00634	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.00279	0.00615	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.0027	0.00594	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.00267	0.00587	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.00261	0.00576	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.00257	0.00567	CbGpPWpGaD
Cetrorelix—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00256	0.00468	CcSEcCtD
Cetrorelix—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00252	0.00461	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.00246	0.00542	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.00246	0.00542	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.00234	0.00515	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.00225	0.00496	CbGpPWpGaD
Cetrorelix—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00219	0.004	CcSEcCtD
Cetrorelix—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00218	0.004	CcSEcCtD
Cetrorelix—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00217	0.00398	CcSEcCtD
Cetrorelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.00216	0.00476	CbGpPWpGaD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.00213	0.0047	CbGpPWpGaD
Cetrorelix—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00206	0.00377	CcSEcCtD
Cetrorelix—GNRHR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.00204	0.0045	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.00204	0.0045	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.00193	0.00425	CbGpPWpGaD
Cetrorelix—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00186	0.0034	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.0018	0.00397	CbGpPWpGaD
Cetrorelix—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00178	0.00326	CcSEcCtD
Cetrorelix—GNRHR—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.00175	0.00386	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.00172	0.00379	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.00167	0.00369	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.00165	0.00363	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.00165	0.00363	CbGpPWpGaD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.00164	0.00361	CbGpPWpGaD
Cetrorelix—Rash—Prednisone—chronic obstructive pulmonary disease	0.00159	0.00291	CcSEcCtD
Cetrorelix—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00159	0.00291	CcSEcCtD
Cetrorelix—Headache—Prednisone—chronic obstructive pulmonary disease	0.00158	0.00289	CcSEcCtD
Cetrorelix—GNRHR—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.00156	0.00345	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.00154	0.0034	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.00151	0.00332	CbGpPWpGaD
Cetrorelix—Nausea—Prednisone—chronic obstructive pulmonary disease	0.0015	0.00274	CcSEcCtD
Cetrorelix—LHCGR—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.00139	0.00306	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.00138	0.00304	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.00137	0.00301	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.00126	0.00278	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.00125	0.00276	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.00121	0.00266	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.0012	0.00265	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.00112	0.00247	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.00112	0.00247	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.00103	0.00228	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.00093	0.00205	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000924	0.00204	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000923	0.00203	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.00088	0.00194	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000845	0.00186	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000841	0.00185	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000839	0.00185	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000808	0.00178	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000751	0.00166	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000746	0.00164	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.000709	0.00156	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000674	0.00149	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000618	0.00136	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.000606	0.00133	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000589	0.0013	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000563	0.00124	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	0.000556	0.00122	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	0.000545	0.0012	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000499	0.0011	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.000475	0.00105	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	0.000458	0.00101	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000451	0.000995	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	0.000419	0.000923	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.000405	0.000893	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	0.000372	0.00082	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	0.000365	0.000804	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	0.000306	0.000675	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	0.00028	0.000618	CbGpPWpGaD
